CVS HEALTH CORP (1CVS.MI) Fundamental Analysis & Valuation

BIT:1CVS • US1266501006

Current stock price

67.05 EUR
+0.64 (+0.96%)
Last:

This 1CVS.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. 1CVS.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1CVS was profitable.
  • In the past year 1CVS had a positive cash flow from operations.
  • 1CVS had positive earnings in each of the past 5 years.
  • 1CVS had a positive operating cash flow in each of the past 5 years.
1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • The Return On Assets of 1CVS (0.70%) is worse than 66.67% of its industry peers.
  • Looking at the Return On Equity, with a value of 2.35%, 1CVS is doing worse than 63.64% of the companies in the same industry.
  • 1CVS has a Return On Invested Capital (4.90%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for 1CVS is in line with the industry average of 6.20%.
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROIC 4.9%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
1CVS.MI Yearly ROA, ROE, ROIC1CVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • 1CVS has a Profit Margin of 0.44%. This is in the lower half of the industry: 1CVS underperforms 66.67% of its industry peers.
  • 1CVS's Profit Margin has declined in the last couple of years.
  • The Operating Margin of 1CVS (2.58%) is worse than 75.76% of its industry peers.
  • In the last couple of years the Operating Margin of 1CVS has declined.
  • The Gross Margin of 1CVS (13.77%) is worse than 63.64% of its industry peers.
  • In the last couple of years the Gross Margin of 1CVS has declined.
Industry RankSector Rank
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
1CVS.MI Yearly Profit, Operating, Gross Margins1CVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. 1CVS.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1CVS is destroying value.
  • The number of shares outstanding for 1CVS has been increased compared to 1 year ago.
  • 1CVS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1CVS has been reduced compared to a year ago.
1CVS.MI Yearly Shares Outstanding1CVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1CVS.MI Yearly Total Debt VS Total Assets1CVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B 250B

2.2 Solvency

  • An Altman-Z score of 2.32 indicates that 1CVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.32, 1CVS is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
  • 1CVS has a debt to FCF ratio of 8.27. This is a slightly negative value and a sign of low solvency as 1CVS would need 8.27 years to pay back of all of its debts.
  • 1CVS has a Debt to FCF ratio (8.27) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.80 indicates that 1CVS is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.80, 1CVS is in line with its industry, outperforming 57.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Altman-Z 2.32
ROIC/WACC0.63
WACC7.75%
1CVS.MI Yearly LT Debt VS Equity VS FCF1CVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • 1CVS has a Current Ratio of 0.84. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1CVS has a Current ratio of 0.84. This is in the lower half of the industry: 1CVS underperforms 63.64% of its industry peers.
  • A Quick Ratio of 0.63 indicates that 1CVS may have some problems paying its short term obligations.
  • 1CVS's Quick ratio of 0.63 is on the low side compared to the rest of the industry. 1CVS is outperformed by 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.63
1CVS.MI Yearly Current Assets VS Current Liabilites1CVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1CVS.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.54% over the past year.
  • 1CVS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.11% yearly.
  • The Revenue has been growing slightly by 7.85% in the past year.
  • Measured over the past years, 1CVS shows a quite strong growth in Revenue. The Revenue has been growing by 8.39% on average per year.
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.88% on average over the next years. This is quite good.
  • 1CVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.08% yearly.
EPS Next Y7.45%
EPS Next 2Y10.69%
EPS Next 3Y12.48%
EPS Next 5Y10.88%
Revenue Next Year1.39%
Revenue Next 2Y2.92%
Revenue Next 3Y3.5%
Revenue Next 5Y4.08%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1CVS.MI Yearly Revenue VS Estimates1CVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
1CVS.MI Yearly EPS VS Estimates1CVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. 1CVS.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.48, the valuation of 1CVS can be described as reasonable.
  • 1CVS's Price/Earnings ratio is rather cheap when compared to the industry. 1CVS is cheaper than 84.85% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.21, 1CVS is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 10.68, the valuation of 1CVS can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, 1CVS is valued a bit cheaper than the industry average as 78.79% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.10, 1CVS is valued rather cheaply.
Industry RankSector Rank
PE 11.48
Fwd PE 10.68
1CVS.MI Price Earnings VS Forward Price Earnings1CVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1CVS.
Industry RankSector Rank
P/FCF 12.63
EV/EBITDA N/A
1CVS.MI Per share data1CVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • 1CVS's earnings are expected to grow with 12.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.54
PEG (5Y)N/A
EPS Next 2Y10.69%
EPS Next 3Y12.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. 1CVS.MI Dividend Analysis

5.1 Amount

  • 1CVS has a Yearly Dividend Yield of 3.70%.
  • 1CVS's Dividend Yield is rather good when compared to the industry average which is at 1.93. 1CVS pays more dividend than 93.94% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, 1CVS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.7%

5.2 History

  • The dividend of 1CVS has a limited annual growth rate of 5.96%.
Dividend Growth(5Y)5.96%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1CVS pays out 192.14% of its income as dividend. This is not a sustainable payout ratio.
  • 1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP192.14%
EPS Next 2Y10.69%
EPS Next 3Y12.48%
1CVS.MI Yearly Income VS Free CF VS Dividend1CVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
1CVS.MI Dividend Payout.1CVS.MI Dividend Payout, showing the Payout Ratio.1CVS.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1CVS.MI Fundamentals: All Metrics, Ratios and Statistics

CVS HEALTH CORP

BIT:1CVS (3/13/2026, 7:00:00 PM)

67.05

+0.64 (+0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners90.76%
Inst Owner ChangeN/A
Ins Owners0.98%
Ins Owner ChangeN/A
Market Cap85.30B
Revenue(TTM)402.07B
Net Income(TTM)1.77B
Analysts79.39
Price Target81.48 (21.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.7%
Yearly Dividend2.32
Dividend Growth(5Y)5.96%
DP192.14%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.24%
Min EPS beat(2)8.8%
Max EPS beat(2)15.69%
EPS beat(4)4
Avg EPS beat(4)19.56%
Min EPS beat(4)8.8%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)7.29%
EPS beat(12)10
Avg EPS beat(12)6.2%
EPS beat(16)14
Avg EPS beat(16)5.76%
Revenue beat(2)2
Avg Revenue beat(2)2.03%
Min Revenue beat(2)1.02%
Max Revenue beat(2)3.04%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.02%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.75%
Revenue beat(12)9
Avg Revenue beat(12)1.31%
Revenue beat(16)13
Avg Revenue beat(16)2.17%
PT rev (1m)1.96%
PT rev (3m)5.32%
EPS NQ rev (1m)0.35%
EPS NQ rev (3m)-0.37%
EPS NY rev (1m)0.16%
EPS NY rev (3m)0.47%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-1.71%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-3.21%
Valuation
Industry RankSector Rank
PE 11.48
Fwd PE 10.68
P/S 0.25
P/FCF 12.63
P/OCF 9.26
P/B 1.31
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.84
EY8.71%
EPS(NY)6.28
Fwd EY9.36%
FCF(TTM)5.31
FCFY7.92%
OCF(TTM)7.24
OCFY10.79%
SpS273.51
BVpS51.16
TBVpS-24.33
PEG (NY)1.54
PEG (5Y)N/A
Graham Number81.99
Profitability
Industry RankSector Rank
ROA 0.7%
ROE 2.35%
ROCE 6.3%
ROIC 4.9%
ROICexc 5.23%
ROICexgc 18.66%
OM 2.58%
PM (TTM) 0.44%
GM 13.77%
FCFM 1.94%
ROA(3y)1.95%
ROA(5y)2.24%
ROE(3y)6.46%
ROE(5y)7.21%
ROIC(3y)5.46%
ROIC(5y)6.31%
ROICexc(3y)5.85%
ROICexc(5y)6.83%
ROICexgc(3y)22.7%
ROICexgc(5y)25.24%
ROCE(3y)7.06%
ROCE(5y)8.13%
ROICexgc growth 3Y-15.72%
ROICexgc growth 5Y-3.91%
ROICexc growth 3Y-15.74%
ROICexc growth 5Y-5.12%
OM growth 3Y-19.74%
OM growth 5Y-12.87%
PM growth 3Y-30.97%
PM growth 5Y-30.29%
GM growth 3Y-6.6%
GM growth 5Y-5.48%
F-Score6
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 8.27
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.7%
Interest Coverage -3.47
Cash Conversion N/A
Profit Quality 441.57%
Current Ratio 0.84
Quick Ratio 0.63
Altman-Z 2.32
F-Score6
WACC7.75%
ROIC/WACC0.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.77%
Cap/Sales(5y)0.8%
Profit Quality(3y)234.42%
Profit Quality(5y)242.41%
High Growth Momentum
Growth
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
EPS Next Y7.45%
EPS Next 2Y10.69%
EPS Next 3Y12.48%
EPS Next 5Y10.88%
Revenue 1Y (TTM)7.85%
Revenue growth 3Y7.63%
Revenue growth 5Y8.39%
Sales Q2Q%8.17%
Revenue Next Year1.39%
Revenue Next 2Y2.92%
Revenue Next 3Y3.5%
Revenue Next 5Y4.08%
EBIT growth 1Y6.02%
EBIT growth 3Y-13.61%
EBIT growth 5Y-5.55%
EBIT Next Year24.52%
EBIT Next 3Y15.26%
EBIT Next 5YN/A
FCF growth 1Y23.41%
FCF growth 3Y-16.58%
FCF growth 5Y-10.28%
OCF growth 1Y16.82%
OCF growth 3Y-13.04%
OCF growth 5Y-7.68%

CVS HEALTH CORP / 1CVS.MI Fundamental Analysis FAQ

What is the fundamental rating for 1CVS stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1CVS.MI.


What is the valuation status for 1CVS stock?

ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.


How profitable is CVS HEALTH CORP (1CVS.MI) stock?

CVS HEALTH CORP (1CVS.MI) has a profitability rating of 2 / 10.


What is the financial health of CVS HEALTH CORP (1CVS.MI) stock?

The financial health rating of CVS HEALTH CORP (1CVS.MI) is 3 / 10.


What is the earnings growth outlook for CVS HEALTH CORP?

The Earnings per Share (EPS) of CVS HEALTH CORP (1CVS.MI) is expected to grow by 7.45% in the next year.